Skip to content
Clinical Trials – home

Mycophenolic Acid: A Comprehensive Guide for Patients

13 / 18
trials open to patients / all trials
23+
Countries

In short

Mycophenolic acid is an immunosuppressant drug that has been the subject of several clinical trials exploring its use in organ transplantation and autoimmune conditions. This article summarizes key findings from recent studies investigating mycophenolic acid's efficacy, safety profile, and potential applications across different patient populations and treatment protocols.

At a glance

Primary Uses
Prevention of organ rejection in transplant patients, particularly kidney transplants; Treatment of autoimmune conditions like lupus nephritis
Mechanism of Action
Inhibits inosine monophosphate dehydrogenase (IMPDH), suppressing T and B lymphocyte proliferation
Common Dosages
720 mg to 1440 mg per day, often divided into two doses
Formulations
Enteric-coated tablets (e.g., Myfortic), standard tablets
Combination Therapy
Often used with other immunosuppressants like tacrolimus, cyclosporine, and corticosteroids
Key Outcomes Measured
Incidence of acute rejection, renal function, proteinuria, adverse events
Potential Side Effects
Gastrointestinal issues, increased risk of infections, blood disorders
Monitoring
Regular blood tests, assessment of kidney function, screening for infections

What is Mycophenolic Acid?

Mycophenolic acid is an immunosuppressant medication used primarily in organ transplant patients to prevent rejection. It's also known by several other names, including mycophenolate sodium, mycophenolate mofetil, Myfortic, and Cellcept. This drug works by suppressing your immune system to prevent it from attacking the transplanted organ.

Conditions Treated

Mycophenolic acid is used to treat several conditions:

  • Kidney transplantation: It's commonly used to prevent rejection in kidney transplant recipients.
  • Heart transplantation: Some studies have explored its use in heart transplant patients.
  • Lupus nephritis: This is a type of kidney inflammation caused by lupus. Mycophenolic acid has shown promise in treating this condition.
  • Autoimmune uveitis: This is an inflammation of the eye that can be treated with mycophenolic acid in some cases.

How It Works

Mycophenolic acid works by inhibiting an enzyme called inosine monophosphate dehydrogenase (IMPDH). This enzyme is crucial for the production of guanosine nucleotides, which are essential for the growth of T and B lymphocytes (types of white blood cells). By blocking this enzyme, mycophenolic acid prevents these immune cells from multiplying, thus suppressing the immune response.

Forms and Dosage

Mycophenolic acid comes in two main forms:

  • Mycophenolate mofetil (Cellcept): This is the original form of the drug.
  • Enteric-coated mycophenolate sodium (Myfortic): This is a newer formulation designed to reduce gastrointestinal side effects.

The typical dosage for kidney transplant patients is 720 mg twice daily for Myfortic, or 1000 mg twice daily for Cellcept. However, dosages may vary depending on the specific condition being treated and individual patient factors.

Effectiveness

Mycophenolic acid has been shown to be effective in preventing organ rejection in transplant patients. In kidney transplant recipients, it can help reduce the risk of acute rejection episodes. For lupus nephritis, studies have shown that it can induce remission in a significant number of patients.

Side Effects

Like all medications, mycophenolic acid can cause side effects. Some of the most common include:

  • Gastrointestinal issues: These can include diarrhea, nausea, and stomach pain. The enteric-coated form (Myfortic) was developed to help reduce these side effects.
  • Increased risk of infections: Because it suppresses the immune system, mycophenolic acid can make you more susceptible to infections.
  • Blood disorders: It may cause anemia (low red blood cells), leukopenia (low white blood cells), or thrombocytopenia (low platelets).

Special Considerations

There are several important things to keep in mind when taking mycophenolic acid:

  • Food interactions: Some studies have looked at how food affects the absorption of mycophenolic acid. It's important to take it consistently either with or without food as directed by your doctor.
  • Pregnancy: Mycophenolic acid can cause birth defects and should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus.
  • Regular monitoring: Your doctor will likely want to monitor your blood levels regularly to ensure the medication is working properly and to check for any potential side effects.
  • Other medications: Mycophenolic acid is often used in combination with other immunosuppressants, such as tacrolimus or cyclosporine. Make sure your doctor knows about all medications you're taking.

Questions people often ask

Conditions where Mycophenolic Acid is being studied

Each condition opens its own overview and trial list

Trials with Mycophenolic Acid

Recruiting trials first

See all 18 →
Quick filters
  • Participants:Adults
  • Participants:All ages
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.